XML 23 R15.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES
3 Months Ended
Mar. 31, 2022
INCOME TAXES  
INCOME TAXES

NOTE J- INCOME TAXES

 

                The Company follows ASC 740 “Income Taxes” (“ASC 740”) which prescribes the asset and liability method whereby deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and are measured using the enacted laws and tax rates that will be in effect when the differences are expected to reverse.  The measurement of net, deferred tax assets is reduced, if necessary, by a valuation allowance for any tax benefits that are not expected to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that such tax rate changes are enacted.   Under ASC 740, tax benefits are recorded only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards.

 

                On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. With regards to the use of net losses incurred for 2018 and later, such net operating losses have no expiration date, while net operating loss carryforwards can only be used to offset up to 80% of taxable income. Net operating losses incurred prior to 2018 may be fully utilized to offset taxable income, but expire in 20 years.

 

A reconciliation of the U.S. Federal statutory income tax rate to the effective income tax rate is as follows:

 

 

 

Quarter Ended

March 31, 2022

 

 

Quarter Ended

March 31, 2021

 

Tax expense at federal statutory rate

 

 

(21)%

 

 

(21)%

State tax expense, net of federal tax effect

 

 

0%

 

 

0%

Increase in valuation allowance

 

 

21%

 

 

21%

Effective income tax rate

 

 

(0)%

 

 

(0)%

 

Deferred income taxes reflect the temporary differences between the financial statement carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, adjusted by the relevant tax rate. The components of deferred tax assets and liabilities are as follows:

 

 

 

March 31, 2022

 

 

December 31, 2021

 

 

 

 

 

 

 

 

Inventory capitalization

 

$8,000

 

 

$8,000

 

Inventory allowance

 

 

68,000

 

 

 

72,000

 

Allowance for doubtful accounts

 

 

1,000

 

 

 

1,000

 

Accrued compensation

 

 

18,000

 

 

 

18,000

 

Stock based compensation

 

 

159,000

 

 

 

160,000

 

Deferred wages payable

 

 

18,000

 

 

 

21,000

 

Depreciation – Property, Plant & Equipment

 

 

(24,000)

 

 

(24,000)

Research and development credits

 

 

24,000

 

 

 

24,000

 

Net operating loss carry-forwards

 

 

2,730,000

 

 

 

2,631,000

 

Total deferred income tax assets, net

 

 

3,002,000

 

 

 

2,911,000

 

Less: valuation allowance

 

 

(3,002,000)

 

 

(2,911,000)

Net deferred income tax assets

 

$0

 

 

 

0

 

 

The valuation allowance for deferred income tax assets was $3,002,000 as of March 31, 2022 and $2,911,000 as of December 31, 2021. The net change in the deferred income tax assets valuation allowance was $91,000 for the three month ended March 31, 2022. The Company believes that it is more likely than not that the deferred tax assets will not be realized.

 

As of March 31, 2022, the prior full three years remain open for examination by the federal or state regulatory agencies for purposes of an audit for tax purposes.

 

At March 31, 2022, the Company had Federal and state net operating loss carry-forwards for income tax purposes of approximately $10,100,000 and research and development credits of $24,000. The Company’s net operating loss carry-forwards began to expire in 2022 and continue to expire through 2037. Net operating losses incurred from 2018 to date have no expiration date. In assessing the reliability of deferred income tax assets, management considers whether or not it is more likely than not that some portion or all deferred income tax assets, net, will be realized. The ultimate realization of net deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the projected future taxable income and tax planning strategies in making this assessment.

 

The Company’s ability to utilize the operating loss carry-forwards and research and development credits may be subject to an annual limitation in future periods pursuant to Section 382 and Section 383 of the Internal Revenue Code of 1986, as amended, if future changes in ownership occur.

 

The Company recognizes potential interest and penalties related to income tax positions as a component of the provision for income taxes on operations. The Company does not anticipate that total unrecognized tax benefits will materially change in the next twelve months.